drugset / Trial / NCT01486238
Pegaptanib for Retinal Edema Secondary to Diabetic Vascular Disease(Preserve) Study
RandomizedParallel-groupDouble-blindTreatment
Summary
Intravitreal injections of pegaptanib every 4 weeks will be efficacious in treating Diabetic Macular Edema (DME), as compared to injections every 6 weeks.
Timeline
- Start
- 2009-04
- Primary completion
- 2011-07
- Completion
- 2011-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | pegaptanib sodium | Aptamer | 0.3 mg | Intravitreal |